These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36462469)

  • 21. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. French validation of the Brief International Cognitive Assessment for Multiple Sclerosis.
    Maubeuge N; Deloire MSA; Brochet B; Erhlé N; Charré-Morin J; Saubusse A; Ruet A;
    Rev Neurol (Paris); 2021; 177(1-2):73-79. PubMed ID: 32713736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Costabile T; Signoriello E; Lauro F; Altieri M; Ziello AR; D'Ambrosio A; Bisecco A; Maniscalco G; Bonavita S; Gallo A; Brescia Morra V; Lus G; Saccà F; Russo CV
    Mult Scler Relat Disord; 2023 Jun; 74():104723. PubMed ID: 37086633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpreting the clinical importance of the relationship between subjective fatigue and cognitive impairment in multiple sclerosis (MS): How BICAMS performance is affected by MS-related fatigue.
    Bellew D; Davenport L; Monaghan R; Cogley C; Gaughan M; Yap SM; Tubridy N; Bramham J; McGuigan C; O'Keeffe F
    Mult Scler Relat Disord; 2022 Nov; 67():104161. PubMed ID: 36126538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study of the correlation between gray matter atrophy in multiple sclerosis and impairment of cognitive function domains].
    Han J; Wang QJ; Wang CH; Li ZH; Bai RH; Zhang X; Liu JG
    Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):666-673. PubMed ID: 38951090
    [No Abstract]   [Full Text] [Related]  

  • 29. Cognitive and brain reserve in multiple sclerosis--A cross-sectional study.
    Ifantopoulou P; Artemiadis AK; Bakirtzis C; Zekiou K; Papadopoulos TS; Diakogiannis I; Hadjigeorgiou G; Grigoriadis N; Orologas A
    Mult Scler Relat Disord; 2019 Oct; 35():128-134. PubMed ID: 31374461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year regional brain volume changes as potential predictors of cognitive function in multiple sclerosis: a pilot study.
    Meira T; Coelho A; Onat S; Ruano L; Cerqueira JJ
    Ir J Med Sci; 2024 Apr; 193(2):957-965. PubMed ID: 37773245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis.
    Artemiadis A; Bakirtzis C; Chatzittofis A; Christodoulides C; Nikolaou G; Boziki MK; Grigoriadis N
    Mult Scler Relat Disord; 2021 Apr; 49():102751. PubMed ID: 33465758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated cognitive impairment in people with multiple sclerosis: frequency, MRI patterns and its development over time.
    Bouman PM; van Dam MA; Jonkman LE; Steenwijk MD; Schoonheim MM; Geurts JJG; Hulst HE
    J Neurol; 2024 May; 271(5):2159-2168. PubMed ID: 38286843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief Computer-Based Information Processing Measures are Linked to White Matter Integrity in Pediatric-Onset Multiple Sclerosis.
    Bartlett E; Shaw M; Schwarz C; Feinberg C; DeLorenzo C; Krupp LB; Charvet LE
    J Neuroimaging; 2019 Jan; 29(1):140-150. PubMed ID: 30285300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.
    Vanotti S; Smerbeck A; Benedict RH; Caceres F
    Clin Neuropsychol; 2016 Oct; 30(7):1023-31. PubMed ID: 27668977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
    Maubeuge N; Deloire MS; Brochet B; Charré-Morin J; Saubusse A; Ruet A
    Mult Scler; 2022 Jun; 28(7):1112-1120. PubMed ID: 34766866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.
    Faiss JH; Dähne D; Baum K; Deppe R; Hoffmann F; Köhler W; Kunkel A; Lux A; Matzke M; Penner IK; Sailer M; Zettl UK
    BMJ Open; 2014 Apr; 4(4):e004409. PubMed ID: 24722197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability and validity of the Arabic version of brief international cognitive assessment for multiple sclerosis in Egyptian pediatric multiple sclerosis patients.
    Abualhasan A; Naseer MA; Shalaby N; El-Jaafary SI; Farghaly M; Shehata HS; Doma ES; Al-Azayem SA
    Mult Scler Relat Disord; 2024 Feb; 82():105374. PubMed ID: 38134604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.
    Hildesheim FE; Benedict RHB; Zivadinov R; Dwyer MG; Fuchs T; Jakimovski D; Weinstock-Guttman B; Bergsland N
    J Neurol; 2021 Dec; 268(12):4796-4808. PubMed ID: 33997915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.